Back to search

Allele specific Taqman-based real-time PCR assay to quantify circulating BRAFV600E mutated DNA in plasma of melanoma patients

Data up to Jan 2025

Published2010
Citations60
References27

Total Citations Per Year

Abstract

References (27)

The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments

2009 • 14,044 citations

Mutations of the BRAF gene in human cancer

2002 • 10,249 citations

High frequency of BRAF mutations in nevi

2002 • 1,701 citations

Circulating nucleic acids (CNAs) and cancer—A survey

2006 • 821 citations

The Raf/MEK/ERK pathway: new concepts of activation

2001 • 716 citations

Differential Regulation of Raf-1, A-Raf, and B-Raf by Oncogenic Ras and Tyrosine Kinases

1997 • 446 citations

Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation.

2003 • 432 citations

A pivotal role for ERK in the oncogenic behaviour of malignant melanoma?

2003 • 327 citations

Incidence of BRAF Oncogene Mutation and Clinical Relevance for Primary Cutaneous Melanomas

2004 • 209 citations

Melanoma genetics and the development of rational therapeutics

2005 • 184 citations

High-Resolution Melting Analysis for Rapid Detection ofKRAS, BRAF,andPIK3CAGene Mutations in Colorectal Cancer

2008 • 165 citations

Utility of Circulating B-RAF DNA Mutation in Serum for Monitoring Melanoma Patients Receiving Biochemotherapy

2007 • 159 citations

Detection of Gene Amplification in Archival Breast Cancer Specimens by Laser-Assisted Microdissection and Quantitative Real-Time Polymerase Chain Reaction

2000 • 147 citations

BRAF somatic mutations in malignant melanoma and melanocytic naevi

2006 • 115 citations

Is the role of circulating DNA as a biomarker of cancer being prematurely overrated?

2009 • 103 citations

Detection of mutated KRAS2 sequences as tumor markers in plasma/serum of patients with gastrointestinal cancer.

2000 • 85 citations

Recent progress in understanding the pathology of malignant melanoma

2009 • 78 citations

Detection of mutated BRAFV600E variant in circulating DNA of stage III–IV melanoma patients

2007 • 75 citations

Clinical significance of BRAF mutations in metastatic melanoma.

2004 • 62 citations

High Sensitivity Scanning of Colorectal Tumors and Matched Plasma DNA for Mutations in APC, TP53, K‐RAS, and BRAF Genes with a Novel DHPLC Fluorescence Detection Platform

2004 • 56 citations

Therapeutic Strategies for Targeting BRAF in Human Cancer

2007 • 47 citations

Detection of Mutant BRAF Alleles in the Plasma of Patients with Metastatic Melanoma

2007 • 43 citations

Using genetics and genomics strategies to personalize therapy for cancer: Focus on melanoma

2010 • 35 citations

Selective Amplification of Rare Mutations Using Locked Nucleic Acid Oligonucleotides that Competitively Inhibit Primer Binding to Wild-Type DNA

2007 • 33 citations

Diagnostic potential of circulating nucleic acids for oncology

2003 • 26 citations

Molecular and genetic mechanisms in melanoma.

2008 • 24 citations

Mutant Form of BRAF Gene in Blood Plasma of Cancer Patients

2004 • 17 citations

Cited By (0)

Loading...
Allele specific Taqman-based real-time PCR assay to quantify circulating BRAFV600E… (2010) – Clinica Chimica Acta | Metascience Observatory Explorer